Corebridge-Financial

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-14
Total Holdings
3,016
Total Value
17392076023
Accession Number
0001889539-25-000038
Form Type
13F-HR
Manager Name
Corebridge-Financial
Data Enrichment
98% identified
2,948 identified68 unidentified

Holdings

3,016 positions • $17.4B total value
Manager:
Search and click to pin securities to the top
Page 144 of 151
ULTRALIFE CORP
Shares:4.9K
Value:$26.5K
% of Portfolio:0.0% ($26.5K/$17.4B)
GYRE THERAPEUTICS, INC.
Shares:3.4K
Value:$26.4K
% of Portfolio:0.0% ($26.4K/$17.4B)
TScan Therapeutics, Inc.
Shares:19.0K
Value:$26.3K
% of Portfolio:0.0% ($26.3K/$17.4B)
SUTRO BIOPHARMA, INC.
Shares:40.1K
Value:$26.1K
% of Portfolio:0.0% ($26.1K/$17.4B)
STEM, INC.
Shares:74.4K
Value:$26.1K
% of Portfolio:0.0% ($26.1K/$17.4B)
LEXICON PHARMACEUTICALS, INC.
Shares:56.2K
Value:$25.9K
% of Portfolio:0.0% ($25.9K/$17.4B)
Brookfield Renewable Corp
Shares:922
Value:$25.7K
% of Portfolio:0.0% ($25.7K/$17.4B)
Ispire Technology Inc.
Shares:9.4K
Value:$25.7K
% of Portfolio:0.0% ($25.7K/$17.4B)
Legend Biotech Corp
Shares:740
Value:$25.1K
% of Portfolio:0.0% ($25.1K/$17.4B)
91854V206
Shares:4.7K
Value:$25.1K
% of Portfolio:0.0% ($25.1K/$17.4B)
Maiden Holdings, Ltd.
Shares:43.9K
Value:$25.0K
% of Portfolio:0.0% ($25.0K/$17.4B)
LiveOne, Inc.
Shares:35.6K
Value:$24.9K
% of Portfolio:0.0% ($24.9K/$17.4B)
Actinium Pharmaceuticals, Inc.
Shares:15.4K
Value:$24.8K
% of Portfolio:0.0% ($24.8K/$17.4B)
EZCORP INC
Shares:1.7K
Value:$24.7K
% of Portfolio:0.0% ($24.7K/$17.4B)
Caesarstone Ltd.
Shares:10.1K
Value:$24.6K
% of Portfolio:0.0% ($24.6K/$17.4B)
Kyverna Therapeutics, Inc.
Shares:12.6K
Value:$24.4K
% of Portfolio:0.0% ($24.4K/$17.4B)
Lineage, Inc.
Shares:415
Value:$24.3K
% of Portfolio:0.0% ($24.3K/$17.4B)
MAMMOTH ENERGY SERVICES, INC.
Shares:11.9K
Value:$24.3K
% of Portfolio:0.0% ($24.3K/$17.4B)
CervoMed Inc.
Shares:2.6K
Value:$24.2K
% of Portfolio:0.0% ($24.2K/$17.4B)
Inozyme Pharma, Inc.
Shares:26.3K
Value:$23.9K
% of Portfolio:0.0% ($23.9K/$17.4B)